Teva Pharmaceutical Industries Aktie

Kaufen
Verkaufen
15,90 EUR +0,50 EUR +3,25 %
16,78 USD +0,22 USD +1,30 %
Aktien, ETFs, Sparpläne & Kryptos zu Top-Konditionen beim Testsieger von finanztip.de handeln! Du hast schon ein ZERO-Konto? Direkt handeln bei ZERO! Bei einem anderen Broker handeln Smartphone
Div. Rendite 0,00%

WKN 883035

ISIN US8816242098

Symbol TEVA


Teva Pharmaceutical Industries Aktie Analyse

03.06.19 Teva Pharmaceutical Industries Outperform Oppenheimer & Co. Inc.
29.03.19 Teva Pharmaceutical Industries Market Perform BMO Capital Markets
09.01.18 Teva Pharmaceutical Industries Buy Mizuho
11.09.17 Teva Pharmaceutical Industries Buy BTIG Research
17.07.17 Teva Pharmaceutical Industries Outperform RBC Capital Markets
16.06.17 Teva Pharmaceutical Industries Buy Mizuho
03.01.17 Teva Pharmaceutical Industries Buy Maxim Group
16.11.16 Teva Pharmaceutical Industries Buy Deutsche Bank AG
16.11.16 Teva Pharmaceutical Industries Buy Maxim Group
14.11.16 Teva Pharmaceutical Industries Outperform RBC Capital Markets
12.07.16 Teva Pharmaceutical Industries Outperform RBC Capital Markets
10.05.16 Teva Pharmaceutical Industries Buy Deutsche Bank AG
10.05.16 Teva Pharmaceutical Industries Buy Mizuho
09.05.16 Teva Pharmaceutical Industries Buy Maxim Group
20.04.16 Teva Pharmaceutical Industries Outperform RBC Capital Markets
07.12.15 Teva Pharmaceutical Industries Buy Mizuho
07.08.15 Teva Pharmaceutical Industries Outperform BMO Capital Markets
29.07.15 Teva Pharmaceutical Industries Outperform RBC Capital Markets
28.07.15 Teva Pharmaceutical Industries Buy Deutsche Bank AG
28.07.15 Teva Pharmaceutical Industries Buy Argus Research Company
27.07.15 Teva Pharmaceutical Industries Buy Maxim Group
27.07.15 Teva Pharmaceutical Industries Buy Standpoint Research
29.04.15 Teva Pharmaceutical Industries Buy Standpoint Research
24.04.15 Teva Pharmaceutical Industries Market Perform BMO Capital Markets
22.04.15 Teva Pharmaceutical Industries Buy Argus Research Company
07.04.15 Teva Pharmaceutical Industries overweight Barclays Capital
31.03.15 Teva Pharmaceutical Industries Outperform Oppenheimer & Co. Inc.
22.12.14 Teva Pharmaceutical Industries Buy Maxim Group
25.11.14 Teva Pharmaceutical Industries Buy Argus Research Company
10.11.14 Teva Pharmaceutical Industries Buy Maxim Group
31.10.14 Teva Pharmaceutical Industries Buy CRT Capital
14.10.14 Teva Pharmaceutical Industries Buy Standpoint Research
13.12.12 Teva Pharmaceutical Industries outperform Exane-BNP Paribas SA
28.11.12 Teva Pharmaceutical Industries outperform Exane-BNP Paribas SA
05.11.12 Teva Pharmaceutical Industries outperform RBC Capital Markets
02.11.12 Teva Pharmaceutical Industries outperform Exane-BNP Paribas SA
02.11.12 Teva Pharmaceutical Industries buy UBS AG
29.10.12 Teva Pharmaceutical Industries outperform Exane-BNP Paribas SA
22.10.12 Teva Pharmaceutical Industries outperform RBC Capital Markets
17.10.12 Teva Pharmaceutical Industries outperform Exane-BNP Paribas SA
11.10.12 Teva Pharmaceutical Industries buy UBS AG
30.08.12 Teva Pharmaceutical Industries buy UBS AG
06.08.12 Teva Pharmaceutical Industries buy UBS AG
03.08.12 Teva Pharmaceutical Industries outperform Exane-BNP Paribas SA
26.06.12 Teva Pharmaceutical Industries outperform Exane-BNP Paribas SA
26.06.12 Teva Pharmaceutical Industries outperform RBC Capital Markets
25.06.12 Teva Pharmaceutical Industries buy UBS AG
25.05.12 Teva Pharmaceutical Industries buy UBS AG
17.05.12 Teva Pharmaceutical Industries outperform RBC Capital Markets
10.05.12 Teva Pharmaceutical Industries buy UBS AG